Status:
UNKNOWN
Prognostic Value of Pediatric GCS-Pupil Score in Pediatric Patients With Traumatic Brain Injury
Lead Sponsor:
Uludag University
Conditions:
Brain Injuries, Traumatic
Eligibility:
All Genders
Up to 18 years
Brief Summary
There are studies reporting that the survival rate in pediatric patients with abnormal pupillary response is 23% and that pupillary response is effective on mortality and patient outcomes. Studies in ...
Detailed Description
Obtaining a GCS-Pupil score using the total GCS score: 0 points are given for pupillary reaction if both pupils react to light, 1 point if one pupil does not react to light, and 2 points if both pupil...
Eligibility Criteria
Inclusion
- Be under the age of 18,
- Not having mental and motor developmental retardation,
- Having had a traumatic brain injury,
- Alive at admission and followed up for at least 24 hours
Exclusion
- Eye trauma or severe facial trauma that will affect the assessment,
- Those under deep sedation,
- Those who have been administered drugs (Atropine and mydriatic) that will affect the pupillary response.
Key Trial Info
Start Date :
July 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2023
Estimated Enrollment :
128 Patients enrolled
Trial Details
Trial ID
NCT05419739
Start Date
July 1 2022
End Date
July 1 2023
Last Update
June 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bursa Provincial Health Directorate University of Health Sciences Bursa Yuksek Ihtisas Training and Research Hospital
Bursa, Turkey (Türkiye), 16000